Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-53715
Pohl, H B F; Porcheri, C; Mueggler, T; Bachmann, L C; Martino, G; Riethmacher, D; Franklin, R J M; Rudin, M; Suter, U (2011). Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. Journal of Neuroscience, 31(3):1069-1080.
Loss of oligodendrocytes is a feature of many demyelinating diseases including multiple sclerosis. Here, we have established and characterized a novel model of genetically induced adult oligodendrocyte death. Specific primary loss of adult oligodendrocytes leads to a well defined and highly reproducible course of disease development that can be followed longitudinally by magnetic resonance imaging. Histological and ultrastructural analyses revealed progressive myelin vacuolation, in parallel to disease development that includes motor deficits, tremor, and ataxia. Myelin damage and clearance were associated with induction of oligodendrocyte precursor cell proliferation, albeit with some regional differences. Remyelination was present in the mildly affected corpus callosum. Consequences of acutely induced cell death of adult oligodendrocytes included secondary axonal damage. Microglia were activated in affected areas but without significant influx of B-cells, T-helper cells, or T-cytotoxic cells. Analysis of the model on a RAG-1 (recombination activating gene-1)-deficient background, lacking functional lymphocytes, did not change the observed disease and pathology compared with immune-competent mice. We conclude that this model provides the opportunity to study the consequences of adult oligodendrocyte death in the absence of primary axonal injury and reactive cells of the adaptive immune system. Our results indicate that if the blood-brain barrier is not disrupted, myelin debris is not removed efficiently, remyelination is impaired, and axonal integrity is compromised, likely as the result of myelin detachment. This model will allow the evaluation of strategies aimed at improving remyelination to foster axon protection.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Institute of Pharmacology and Toxicology|
04 Faculty of Medicine > Institute of Biomedical Engineering
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||07 Jan 2012 20:26|
|Last Modified:||29 Nov 2013 13:50|
|Publisher:||Society for Neuroscience|
|Citations:||Web of Science®. Times Cited: 44|
Scopus®. Citation Count: 46
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page